Investigational gene-modified immune cell therapy (NCT04119024)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational gene-modified immune cell therapy (NCT04119024), covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors [Phase 1]